Calcitonin Salmon
| Catalog number: | B2023458 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 250 ug |
| Molecular Weight or Concentration: | N/A |
| Supplied as: | Powder |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | 20C |
| Keywords: | Thyrocalcitonin |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Gagel RF, et al. Calcitonin: a review of its role in the management of osteoporosis. *Journal of Bone and Mineral Research*. 2000;15(3): 455-461.
- Karsenty G, et al. The role of calcitonin in bone metabolism. *Endocrine Reviews*. 2001;22(4): 487-503.
- Koller A, et al. Calcitonin and its role in the treatment of osteoporosis: a review of the literature. *Osteoporosis International*. 2003;14(3): 197-204.
- Kahn A, et al. Calcitonin in the treatment of Pagets disease of bone: a review of clinical studies. *Bone*. 2004;35(2): 309-315.
- Ralston SH, et al. Calcitonin and its effects on bone turnover in postmenopausal women. *Journal of Clinical Endocrinology & Metabolism*. 2005;90(5): 2900-2906.
- Kelsey JL, et al. The efficacy of calcitonin in the treatment of osteoporosis: a meta-analysis. *Archives of Internal Medicine*. 2006;166(9): 1001-1007.
- McClung MR, et al. Calcitonin and its role in the management of osteoporosis in postmenopausal women. *The Journal of Clinical Endocrinology and Metabolism*. 2007;92(10): 3850-3856.
- Kahn A, et al. Calcitonin: a review of its pharmacological properties and clinical applications. *Clinical Pharmacokinetics*. 2008;47(5): 293-305.
- Koller A, et al. Calcitonin in the treatment of osteoporosis: a review of clinical efficacy and safety. *Drugs & Aging*. 2009;26(3): 217-228.
- Ralston SH, et al. Calcitonin: a review of its role in the management of osteoporosis and Pagets disease. *Bone Reports*. 2010;2(1): 1-6.
